CBD Global Sciences Inc.
CBDNFOTCHealthcare
$0.04
$-0.00(-2.67%)
Market Cap$2072232
P/E Ratio—
52W High$0.121
52W Low$0.016
CBD Global Sciences Inc. (CBDNF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CBDNF · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2022Report Date: Sep 30, 2022EPS Actual
-$0.01
Revenue
$0.00B
Fiscal Period
Q3 FY2022
FY ends December
Report Date
Sep 30, 2022
After Market Close
CBDNF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$78.12
Rev. $1025.0B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$78.12
Rev. Est.$1025.0B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2022 | Sep 30, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2022 | Jun 30, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2022 | Mar 31, 2022 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2021 | Dec 31, 2021 | — | -$0.04 | — | $0.00B | — | — |
| — Q4 FY2021 | Nov 29, 2021 | — | $0.10 | — | $0.00B | — | — |
| — Q2 FY2021 | Jun 30, 2021 | — | -$0.02 | — | $0.00B | — | — |
| — Q1 FY2021 | Mar 31, 2021 | — | -$0.04 | — | $0.00B | — | — |
| — Q4 FY2020 | Dec 31, 2020 | — | -$0.07 | — | $0.00B | — | — |
Q3 FY2022
Sep 30, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2022
Jun 30, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2022
Mar 31, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2021
Dec 31, 2021
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2021
Nov 29, 2021
EPS Actual
$0.10
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2021
Jun 30, 2021
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2021
Mar 31, 2021
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2020
Dec 31, 2020
EPS Actual
-$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2023 | $0.00 | — | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2022 | Sep 30, 2022 | — | $0.12 | $0.12 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.11 | $0.11 | -3.51% |
| — Q1 FY2022 | Mar 31, 2022 | — | $0.19 | $0.19 | -1.58% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.17 | $0.17 | +0.00% |
| — Q4 FY2021 | Nov 29, 2021 | — | $0.18 | $0.11 | -38.55% |
| — Q2 FY2021 | Jun 30, 2021 | — | $0.31 | $0.24 | -22.65% |
| — Q1 FY2021 | Mar 31, 2021 | — | $0.33 | $0.34 | +2.75% |
| — Q4 FY2020 | Dec 31, 2020 | — | No price data | $0.17 | — |
Q3 FY2022+0.00%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$0.12
Price After
$0.12
Q2 FY2022-3.51%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$0.11
Price After
$0.11
Q1 FY2022-1.58%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$0.19
Price After
$0.19
Q4 FY2021+0.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$0.17
Price After
$0.17
Q4 FY2021-38.55%
Report Date
Nov 29, 2021
EPS Beat/Miss
—
Price Before
$0.18
Price After
$0.11
Q2 FY2021-22.65%
Report Date
Jun 30, 2021
EPS Beat/Miss
—
Price Before
$0.31
Price After
$0.24
Q1 FY2021+2.75%
Report Date
Mar 31, 2021
EPS Beat/Miss
—
Price Before
$0.33
Price After
$0.34
Q4 FY2020—
Report Date
Dec 31, 2020
EPS Beat/Miss
—
Price Before
—
Price After
$0.17
Beat Rate0 / 8 quarters
Largest Move-38.55% (Q4 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CBDNF ends December
CBD Global Sciences Inc. (CBDNF) most recently reported earnings on September 30, 2022 for Q3 FY2022, posting EPS of $-0.01 (in line with the analyst consensus of —). The next CBDNF earnings date is expected around September 1, 2026.
Each quarter, investors track CBDNF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CBDNF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CBDNF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CBDNF earnings · 4 questionsCBD Global Sciences Inc.'s next earnings report is expected around September 1, 2026. CBDNF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CBDNF historically reports after market close (AMC).
CBDNF earnings datewhen is CBDNF earningsCBDNF next earnings datewhen does CBDNF report earningsCBDNF earnings calendar
▸ Source: FMP · CBD Global Sciences Inc. SEC filings · US GAAP · CBD Global Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026